These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

66 related items for PubMed ID: 8351691

  • 1. Study of cyclosporin A blood level during the early post-liver-transplantation period.
    Masini JP, Poirier JM, Weissenburger J, Desnault H, Hannoun L, Balladur P, Nordlinger B, Parc R, Lienhart A, Cheymol G.
    Therapie; 1993; 48(2):163-6. PubMed ID: 8351691
    [Abstract] [Full Text] [Related]

  • 2. CsA levels in the early posttransplant period--predictive of chronic rejection in liver transplantation?
    Soin AS, Rasmussen A, Jamieson NV, Watson CJ, Friend PJ, Wight DG, Calne RY.
    Transplantation; 1995 Apr 27; 59(8):1119-23. PubMed ID: 7732557
    [Abstract] [Full Text] [Related]

  • 3. Early steroid withdrawal after liver transplantation: the Canadian tacrolimus versus microemulsion cyclosporin A trial: 1-year follow-up.
    Greig P, Lilly L, Scudamore C, Erb S, Yoshida E, Kneteman N, Bain V, Ghent C, Marotta P, Grant D, Wall W, Tchervenkov J, Barkun J, Roy A, Marleau D, McAlister V, Peltekian K.
    Liver Transpl; 2003 Jun 27; 9(6):587-95. PubMed ID: 12783400
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK, Montagnino G, Del Castillo D, Margreiter R, Sperschneider H, Olbricht CJ, Krüger B, Ortuño J, Köhler H, Kunzendorf U, Stummvoll HK, Tabernero JM, Mühlbacher F, Rivero M, Arias M, European Tacrolimus vs Cyclosporin Microemulsion Renal Transplantation Study Group.
    Nephrol Dial Transplant; 2005 May 27; 20(5):968-73. PubMed ID: 15741208
    [Abstract] [Full Text] [Related]

  • 5. Is 3-hour cyclosporine blood level superior to trough level in early post-renal transplantation period?
    Mahalati K, Lawen J, Kiberd B, Belitsky P.
    J Urol; 2000 Jan 27; 163(1):37-41. PubMed ID: 10604309
    [Abstract] [Full Text] [Related]

  • 6. Cyclosporine C2 levels in de novo renal allograft recipients: a German multicenter prospective observational study.
    Arns W, Zantvoort F, Abendroth D, Seiter H, Scheuermann EH, Albert U, Stahl R, Fornara P, Fricke L, Neumayer HH, Nagel E, Michel U, Ulbricht B.
    Transplant Proc; 2005 Apr 27; 37(3):1612-5. PubMed ID: 15866687
    [Abstract] [Full Text] [Related]

  • 7. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO, Ehlermann P, Koch A, Remppis A, Katus HA, Dengler TJ.
    Clin Ther; 2006 Jun 27; 28(6):893-905. PubMed ID: 16860172
    [Abstract] [Full Text] [Related]

  • 8. Relationship between pharmacokinetic parameters of cyclosporin and the incidence of acute rejection after heart transplantation.
    Aumente MD, Arizón JM, Segura J, López A, Albornoz R, Cárdenas M, Segura C.
    Transplant Proc; 2005 Nov 27; 37(9):4014-7. PubMed ID: 16386613
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and side-effects of cyclosporine dose monitoring with levels 6 h after the morning dose in heart transplant patients.
    Cantarovich M, Besner JG, Fitchett DH, Latter DA.
    Clin Transplant; 1997 Oct 27; 11(5 Pt 1):399-405. PubMed ID: 9361930
    [Abstract] [Full Text] [Related]

  • 10. The importance of early cyclosporine levels in pediatric kidney transplantation.
    Matas AJ, Gillingham KJ, Chavers BM, Nevins T, Kashtan C, Mauer SM, Payne WD, Gruessner R, Najarian JS.
    Clin Transplant; 1996 Dec 27; 10(6 Pt 1):482-6. PubMed ID: 8996767
    [Abstract] [Full Text] [Related]

  • 11. [A comparative randomized prospective multicenter study of Sandimmune vs Neoral in liver transplantation].
    Roy A, Grant DR, Kneteman NM, Tchervenkov JI, Levy GA, Tan A, Hendricks L.
    Ann Chir; 1998 Dec 27; 52(8):716-21. PubMed ID: 9846420
    [Abstract] [Full Text] [Related]

  • 12. Do cyclosporin profiles provide useful information in the management of renal transplant recipients?
    Bowles MJ, Waters JB, Lechler RI, Williams G.
    Nephrol Dial Transplant; 1996 Aug 27; 11(8):1597-602. PubMed ID: 8856218
    [Abstract] [Full Text] [Related]

  • 13. An open randomized study comparing immunosuppression therapy initiated before or after kidney transplantation in haploidentical living recipients.
    Câmara NO, Dias MF, Pacheco-Silva A.
    Clin Transplant; 2004 Aug 27; 18(4):450-5. PubMed ID: 15233825
    [Abstract] [Full Text] [Related]

  • 14. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
    Levy G, Grazi GL, Sanjuan F, Wu Y, Mühlbacher F, Samuel D, Friman S, Jones R, Cantisani G, Villamil F, Cillo U, Clavien PA, Klintmalm G, Otto G, Pollard S, McCormick PA.
    Liver Transpl; 2006 Oct 27; 12(10):1464-72. PubMed ID: 17004259
    [Abstract] [Full Text] [Related]

  • 15. Cyclosporine profiling with C2 and C0 monitoring improves outcomes after heart transplantation.
    Barnard JB, Thekkudan J, Richardson S, Bittar MN, Martyszczuck R, Hasan J, Khasati N, Keevil B, Yonan N.
    J Heart Lung Transplant; 2006 May 27; 25(5):564-8. PubMed ID: 16678036
    [Abstract] [Full Text] [Related]

  • 16. Decreased incidence of acute graft-versus-host disease by continuous infusion of cyclosporine with a higher target blood level.
    Oshima K, Kanda Y, Nakasone H, Arai S, Nishimoto N, Sato H, Watanabe T, Hosoya N, Izutsu K, Asai T, Hangaishi A, Motokura T, Chiba S, Kurokawa M.
    Am J Hematol; 2008 Mar 27; 83(3):226-32. PubMed ID: 17918253
    [Abstract] [Full Text] [Related]

  • 17. Everolimus and reduced cyclosporine trough levels in maintenance heart transplant recipients.
    Schweiger M, Wasler A, Prenner G, Stiegler P, Stadlbauer V, Schwarz M, Tscheliessnigg K.
    Transpl Immunol; 2006 Jun 27; 16(1):46-51. PubMed ID: 16701176
    [Abstract] [Full Text] [Related]

  • 18. Comparison of Neoral and Sandimmune cyclosporine for induction of immunosuppression after heart transplantation.
    Carrier M, White M, Pellerin M, Pelletier GB, Pelletier LC.
    Can J Cardiol; 1997 May 27; 13(5):469-73. PubMed ID: 9179085
    [Abstract] [Full Text] [Related]

  • 19. Study of cyclosporine level at 2 hours after administration in preoperative kidney transplant recipients for prediction of postoperative optimal cyclosporine dose.
    Sukhavasharin N, Praditpornsilpa K, Avihingsanon Y, Kuoatawintu P, O-Charoen R, Kansanabuch T, Tungsanga K, Eiam-Ong S.
    J Med Assoc Thai; 2006 Aug 27; 89 Suppl 2():S15-20. PubMed ID: 17044449
    [Abstract] [Full Text] [Related]

  • 20. Limitations of C2 monitoring in renal transplant recipients.
    Einecke G, Schütz M, Mai I, Fritsche L, Giessing M, Glander P, Neumayer HH, Budde K.
    Nephrol Dial Transplant; 2005 Jul 27; 20(7):1463-70. PubMed ID: 15840681
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.